SITE MAP
|
CONTACT US
Home
About Biovail
Investor Relations
Products
New Strategic Focus
Careers
See News Archive
Stock
BVF.TO
11.27
-0.21
Sep 05 2008 6:56 PM
BVF
NYSE
10.68
-0.11
09/03/2008 4:01 PM
Biovail Announces Filing of ANDA for Fenofibrate Tablets
08/25/2008 1:00 PM
Biovail Receives Canadian Approval for Ralivia(TM) for the Treatment of Moderately Severe Pain
08/21/2008 8:01 AM
Biovail Appoints Peggy Mulligan Chief Financial Officer
Biovail Contract
Research
Study Participation
Steinbach Careers
© 2007 Biovail Corporation - All Rights Reserved (BIO113B0602)
Privacy Policy
|
Disclaimers